Online citations, reference lists, and bibliographies.
← Back to Search

Specific Surgical Topics: Surgical Management Of Gastrointestinal Stromal Tumors

M. Steves
Published 2017 · Medicine

Save to my Library
Download PDF
Analyze on Scholarcy Visualize in Litmaps
Share
Reduce the time it takes to create your bibliography by a factor of 10 by using the world’s favourite reference manager
Time to take this seriously.
Get Citationsy
Gastrointestinal stromal tumor (GIST) is the most common mesenchymal tumor of the GI tract with a new patient diagnosis of 4000–6000 per year in the USA. The pathological characterization of this tumor and the molecular basis of its treatment in the last several decades illustrate the complexity and beauty of targeted treatment for cancer.
This paper references
10.1016/S0959-8049(98)00375-X
Quantitative methodologies for selection of patients with recurrent abdominopelvic sarcoma for treatment.
B. Berthet (1999)
10.1172/JCI9083
Lessons learned from the development of an abl tyrosine kinase inhibitor for chronic myelogenous leukemia.
B. Druker (2000)
10.1056/NEJM200104053441404
Effect of the tyrosine kinase inhibitor STI571 in a patient with a metastatic gastrointestinal stromal tumor.
H. Joensuu (2001)
10.1200/JCO.2005.05.3439
Surgical management of advanced gastrointestinal stromal tumors after treatment with targeted systemic therapy using kinase inhibitors.
C. Raut (2006)
10.1016/J.HUMPATH.2006.07.002
High incidence of microscopic gastrointestinal stromal tumors in the stomach.
Kaori Kawanowa (2006)
10.1097/01.pas.0000213307.05811.f0
Minute Gastric Sclerosing Stromal Tumors (GIST Tumorlets) Are Common in Adults and Frequently Show c-KIT Mutations
A. Agaimy (2007)
10.1016/j.ejso.2011.06.005
Validation of the Joensuu risk criteria for primary resectable gastrointestinal stromal tumour - the impact of tumour rupture on patient outcomes.
P. Rutkowski (2011)
10.1016/j.jamcollsurg.2012.05.008
Microscopically positive margins for primary gastrointestinal stromal tumors: analysis of risk factors and tumor recurrence.
M. McCarter (2012)
10.1097/SLA.0b013e3182a15eb7
Long-term Results of Adjuvant Imatinib Mesylate in Localized, High-Risk, Primary Gastrointestinal Stromal Tumor: ACOSOG Z9000 (Alliance) Intergroup Phase 2 Trial
R. DeMatteo (2013)
10.1002/jso.23451
Metastasectomy for gastrointestinal stromal tumors
Z. Bamboat (2014)
10.1200/JCO.2013.51.2046
Pathologic and molecular features correlate with long-term outcome after adjuvant therapy of resected primary GI stromal tumor: the ACOSOG Z9001 trial.
C. Corless (2014)



Semantic Scholar Logo Some data provided by SemanticScholar